Suppr超能文献

富血小板纤维蛋白作为半月板修复支架的效用:一项非随机对照队列/随访研究。

Usefulness of platelet-rich fibrin as a scaffold for meniscal repair: A non-randomized controlled cohort/follow-up study.

作者信息

Kemmochi Masahiko

机构信息

Kemmochi Orthopedic Surgery Sports Clinic, KOSSMOS(Kenmochi Orthopaedics Surgery,Sports Medicine,the Organization of Sport), Medical Corporation, 42-1 Higashi-honcho, Ota City, Gunma, 373-0026, Japan.

出版信息

J Orthop. 2024 Feb 16;52:94-101. doi: 10.1016/j.jor.2024.02.009. eCollection 2024 Jun.

Abstract

BACKGROUND

Although regenerative medicine treatment is still in its infancy in Japan, legislation within the past decade has provided opportunities to explore new treatment methods using regenerative medicine. We conducted a 2-year prospective follow-up study to statistically analyze treatment outcomes using platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) as effective scaffolds in meniscal repair.Questions/Purposes.1. Does the use of PRF and PRP for meniscal repair surgery regenerate the meniscus?2. Does augmentation of meniscal repair with PRF effectively improve knee function outcomes?

METHODS

Thirty-five patients underwent arthroscopic meniscal repair with PRP and PRF using new devices with all-inside techniques. Among these, 31 patients were evaluated for clinical outcomes postoperatively, and magnetic resonance imaging (MRI) findings were evaluated. The variables were coded appropriately by creating a new column based on the Kellgren-Lawrence classification over time. Log transformation of different time points (pre, post 6, 12, or 24 months) in relation to Lysholm, International Knee Documentation Committee (IKDC), Japanese Orthopedic Association (JOA), and Tegner scores were performed. Follow-up arthroscopy using a needle scope was performed in some cases 2 years later. The PRP and PRF used were characterized using the Minimum Information for Studies Evaluating Biologics in Orthopaedics classification.

RESULTS

Overall, 31 patients were evaluated (mean age = 39.1 ± 15.7 years; preoperative rehabilitation period = 9.5 ± 7.7 weeks). The PRP had mean platelet and white blood cell concentrations of approximately 5.5- and 3.6-fold, respectively. A significant association existed between sex and deformity deterioration but not in age between the two groups classified by deformity deterioration. Surgical intervention significantly and positively impacted knee function, although no significant changes were found in the activity of the participants over time. MRI findings showed no regeneration of the repaired meniscus; nevertheless, none of them worsened. Furthermore, a case where the traumatic cartilage defect was covered with fibrocartilage-like tissue as a secondary finding was observed.

CONCLUSIONS

Meniscal repair surgery using PRP/PRF is an effective treatment option for improving knee function in patients with knee deformity.

LEVEL OF EVIDENCE

Level III, Non-randomized controlled cohort/follow-up study.

摘要

背景

尽管再生医学治疗在日本仍处于起步阶段,但过去十年的立法为探索使用再生医学的新治疗方法提供了机会。我们进行了一项为期2年的前瞻性随访研究,以统计分析使用富血小板血浆(PRP)和富血小板纤维蛋白(PRF)作为半月板修复有效支架的治疗结果。

问题/目的:

  1. 使用PRF和PRP进行半月板修复手术能否使半月板再生?

  2. 使用PRF增强半月板修复是否能有效改善膝关节功能结果?

方法

35例患者使用全关节镜技术的新设备接受了PRP和PRF的关节镜下半月板修复。其中,31例患者接受了术后临床结果评估,并对磁共振成像(MRI)结果进行了评估。通过基于Kellgren-Lawrence分类随时间创建新列,对变量进行适当编码。对不同时间点(术前、术后6、12或24个月)与Lysholm、国际膝关节文献委员会(IKDC)、日本骨科协会(JOA)和Tegner评分相关的数据进行对数转换。2年后,部分病例使用针式关节镜进行了随访关节镜检查。使用骨科生物制品评估研究的最低信息分类对所用的PRP和PRF进行了特征描述。

结果

总体而言,对31例患者进行了评估(平均年龄 = 39.1 ± 15.7岁;术前康复期 = 9.5 ± 7.7周)。PRP的平均血小板和白细胞浓度分别约为5.5倍和3.6倍。按畸形恶化分类的两组之间,性别与畸形恶化之间存在显著关联,但年龄之间无显著关联。手术干预对膝关节功能有显著的正向影响,尽管随着时间的推移,参与者的活动没有发现显著变化。MRI结果显示修复的半月板没有再生;然而,它们都没有恶化。此外,观察到1例创伤性软骨缺损被纤维软骨样组织覆盖的次要发现病例。

结论

使用PRP/PRF进行半月板修复手术是改善膝关节畸形患者膝关节功能的有效治疗选择。

证据级别

III级,非随机对照队列/随访研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f27/10904893/f314a56640b9/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验